BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18498753)

  • 1. PCNA ubiquitination and REV1 define temporally distinct mechanisms for controlling translesion synthesis in the avian cell line DT40.
    Edmunds CE; Simpson LJ; Sale JE
    Mol Cell; 2008 May; 30(4):519-29. PubMed ID: 18498753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-damage tolerance mediated by PCNA*Ub fusions in human cells is dependent on Rev1 but not Polη.
    Qin Z; Lu M; Xu X; Hanna M; Shiomi N; Xiao W
    Nucleic Acids Res; 2013 Aug; 41(15):7356-69. PubMed ID: 23761444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Werner's Syndrome protein collaborates with REV1 to promote replication fork progression on damaged DNA.
    Phillips LG; Sale JE
    DNA Repair (Amst); 2010 Oct; 9(10):1064-72. PubMed ID: 20691646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of CPD ultraviolet lesion bypass in chicken DT40 cells: polymerase η and PCNA ubiquitylation play identical roles.
    Varga A; Marcus AP; Himoto M; Iwai S; Szüts D
    PLoS One; 2012; 7(12):e52472. PubMed ID: 23272247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
    Pustovalova Y; Maciejewski MW; Korzhnev DM
    J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.
    Hicks JK; Chute CL; Paulsen MT; Ragland RL; Howlett NG; Guéranger Q; Glover TW; Canman CE
    Mol Cell Biol; 2010 Mar; 30(5):1217-30. PubMed ID: 20028736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA ubiquitination is important, but not essential for translesion DNA synthesis in mammalian cells.
    Hendel A; Krijger PH; Diamant N; Goren Z; Langerak P; Kim J; Reissner T; Lee KY; Geacintov NE; Carell T; Myung K; Tateishi S; D'Andrea A; Jacobs H; Livneh Z
    PLoS Genet; 2011 Sep; 7(9):e1002262. PubMed ID: 21931560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair protein MSH2 regulates translesion DNA synthesis following exposure of cells to UV radiation.
    Lv L; Wang F; Ma X; Yang Y; Wang Z; Liu H; Li X; Liu Z; Zhang T; Huang M; Friedberg EC; Tang TS; Guo C
    Nucleic Acids Res; 2013 Dec; 41(22):10312-22. PubMed ID: 24038355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporally distinct translesion synthesis pathways for ultraviolet light-induced photoproducts in the mammalian genome.
    Temviriyanukul P; van Hees-Stuivenberg S; Delbos F; Jacobs H; de Wind N; Jansen JG
    DNA Repair (Amst); 2012 Jun; 11(6):550-8. PubMed ID: 22521143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The translesion DNA polymerases Pol ζ and Rev1 are activated independently of PCNA ubiquitination upon UV radiation in mutants of DNA polymerase δ.
    Tellier-Lebegue C; Dizet E; Ma E; Veaute X; Coïc E; Charbonnier JB; Maloisel L
    PLoS Genet; 2017 Dec; 13(12):e1007119. PubMed ID: 29281621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-dependent regulation of translesion polymerases.
    Chun AC; Jin DY
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):110-5. PubMed ID: 20074045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ubiquitin-binding motif in the translesion DNA polymerase Rev1 mediates its essential functional interaction with ubiquitinated proliferating cell nuclear antigen in response to DNA damage.
    Wood A; Garg P; Burgers PM
    J Biol Chem; 2007 Jul; 282(28):20256-63. PubMed ID: 17517887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for novel interactions between human translesion synthesis polymerases and proliferating cell nuclear antigen.
    Hishiki A; Hashimoto H; Hanafusa T; Kamei K; Ohashi E; Shimizu T; Ohmori H; Sato M
    J Biol Chem; 2009 Apr; 284(16):10552-60. PubMed ID: 19208623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-canonical protein binding site at the monomer-monomer interface of yeast proliferating cell nuclear antigen (PCNA) regulates the Rev1-PCNA interaction and Polζ/Rev1-dependent translesion DNA synthesis.
    Sharma NM; Kochenova OV; Shcherbakova PV
    J Biol Chem; 2011 Sep; 286(38):33557-66. PubMed ID: 21799021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REV1 promotes PCNA monoubiquitylation through interacting with ubiquitylated RAD18.
    Wang Z; Huang M; Ma X; Li H; Tang T; Guo C
    J Cell Sci; 2016 Mar; 129(6):1223-33. PubMed ID: 26795561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TopBP1-mediated DNA processing during mitosis.
    Gallina I; Christiansen SK; Pedersen RT; Lisby M; Oestergaard VH
    Cell Cycle; 2016; 15(2):176-83. PubMed ID: 26701150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases eta and REV1.
    Garg P; Burgers PM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18361-6. PubMed ID: 16344468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.
    Pustovalova Y; Magalhães MT; D'Souza S; Rizzo AA; Korza G; Walker GC; Korzhnev DM
    Biochemistry; 2016 Apr; 55(13):2043-53. PubMed ID: 26982350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translesion synthesis mechanisms depend on the nature of DNA damage in UV-irradiated human cells.
    Quinet A; Martins DJ; Vessoni AT; Biard D; Sarasin A; Stary A; Menck CF
    Nucleic Acids Res; 2016 Jul; 44(12):5717-31. PubMed ID: 27095204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1.
    Ross AL; Simpson LJ; Sale JE
    Nucleic Acids Res; 2005; 33(4):1280-9. PubMed ID: 15741181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.